Chris Mason

Christopher Mason is a highly experienced engineering leader in the health tech sector, currently serving as the Head of Engineering at Navio since July 2019, where contributions include architecting a no-code SaaS platform for cancer patient engagement. Prior to this, Christopher held the position of Director of Software Engineering at Myriad Genetics, driving the development of critical tools that facilitated a significant acquisition, and previously led the Digital Products engineering team at Counsyl, enhancing clinical genetic testing processes. Earlier career roles involved software development and architecture at Thetus Corporation, Proteome Software, Mayo Clinic, and Sequel Genetics, alongside a solid academic foundation in Computer Science and Biology from Carnegie Mellon University.